Johnson & Johnson’s Janssen Pharmaceuticals failed to inform expectant mothers of risks that its epilepsy drug Topamax could cause birth defects, a lawyer for the mother of a Virginia 6-year-old told a jury.
Vivus Inc. said its effort to win regulatory approval for weight-loss pill Qnexa may be helped by a study showing little risk of birth defects in children of women who took one of the medicine’s ingredients.
Diageo Plc agreed to pay more than A$1 million ($1 million) to an Australian victim of a drug that can cause birth defects, opening the way for settlement talks with more than 100 other affected people, a law firm said.
GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements.
GlaxoSmithKline Plc, the U.K.’s largest drugmaker, will pay $105 million to settle claims by California, New York and more than 40 other states that it illegally promoted asthma and antidepressant drugs.